1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP SC481634 2023-08-01 2024-07-31 SC481634 2024-07-31 SC481634 2023-07-31 SC481634 2022-08-01 2023-07-31 SC481634 2023-07-31 SC481634 2022-07-31 SC481634 bus:Director1 2023-08-01 2024-07-31 SC481634 core:WithinOneYear 2024-07-31 SC481634 core:WithinOneYear 2023-07-31 SC481634 bus:Micro-entities 2023-08-01 2024-07-31 SC481634 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 SC481634 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 SC481634 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 SC481634 bus:FullAccounts 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: SC481634
IP Oncology Limited
Filleted Unaudited Financial Statements
For the year ended
31 July 2024
IP Oncology Limited
Statement of Financial Position
31 July 2024
2024
2023
£
£
Current assets
8,546
12,075
Creditors: amounts falling due within one year
386,229
380,086
---------
---------
Net current liabilities
377,683
368,011
---------
---------
Total assets less current liabilities
( 377,683)
( 368,011)
---------
---------
Capital and reserves
( 377,683)
( 368,011)
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Going concern
The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The Company is supported through loans from the director. The director has confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the director will continue to support the Company. Given the current position, the director believes that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, the director continues to adopt the going concern basis in preparing the financial statements.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 July 2025 , and are signed on behalf of the board by:
Dr C J Wareing
Director
Company registration number: SC481634
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 61 Dublin St, Edinburgh, EH3 6NL, Scotland.